Rapt Therapeutics Net Other Investing Changes (Quarterly) Insights

Rapt Therapeutics, Inc. (RAPT)

57.65 +0.01 (+0.02%) USD | NASDAQ | Jan 23, 09:36

View Net Other Investing Changes (Quarterly) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Other Investing Changes (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Other Investing Changes (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Other Investing Changes (Quarterly) Benchmarks

Start Trial

Replimune Group, Inc.	--
Olema Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--